Harbour Trust & Investment Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,044
Closed -$385K 156
2024
Q4
$385K Buy
1,044
+315
+43% +$132K 0.04% 122
2024
Q3
$379K Hold
729
0.04% 123
2024
Q2
$395K Sell
729
-40
-5% -$21.1K 0.05% 122
2024
Q1
$399K Hold
769
0.05% 129
2023
Q4
$363K Buy
+769
New +$356K 0.05% 133

Other funds holding ELV

Harbour Trust & Investment Management's ELV Position: Q1 2025 in Review

Harbour Trust & Investment Management sold out of Elevance Health (ELV) in Q1 2025, closing a stake of 1,044 shares — an estimated $385K sold.

Harbour Trust & Investment Management first reported a position in ELV in Q4 2023 and held it in 5 quarters. The position peaked at $399K in Q1 2024. 1,661 funds tracked by Wall St. Rank hold ELV as of Q1 2025.

  • Harbour Trust & Investment Management reported no remaining Elevance Health position as of Q1 2025 after selling out during the quarter.
  • Harbour Trust & Investment Management sold 1,044 Elevance Health shares in Q1 2025, an estimated $385K.
  • Harbour Trust & Investment Management first reported a position in Elevance Health in Q4 2023 and held it in 5 quarters.
  • Harbour Trust & Investment Management's Elevance Health position peaked at $399K in Q1 2024.
  • 1,661 funds tracked by Wall St. Rank held Elevance Health as of Q1 2025.

Based on Harbour Trust & Investment Management's 13F filing for Q1 2025, filed 28 Apr 2025.